Yi Liu, Harris Z. Whiteson, Jingyao Hong, Nidhi Ghildayal, Omid Shafaat, Clifford R. Weiss, Robert A. Pol, Aarti Mathur, Babak J. Orandi, Dorry L. Segev, Mara A. McAdams-DeMarco
{"title":"Pre- and Post-Kidney Transplant Abdominal Computed Tomography-Based Muscle Measurements and Post-KT Outcomes","authors":"Yi Liu, Harris Z. Whiteson, Jingyao Hong, Nidhi Ghildayal, Omid Shafaat, Clifford R. Weiss, Robert A. Pol, Aarti Mathur, Babak J. Orandi, Dorry L. Segev, Mara A. McAdams-DeMarco","doi":"10.1111/ctr.70281","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Early post-kidney transplant (KT) changes likely impact body composition, resulting in adverse post-KT outcomes. We estimated post-KT trajectories of computed tomography (CT)-based muscle quantity/quality and tested whether they were associated with mortality and death-censored graft loss (DCGL) among frail and nonfrail recipients.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We leveraged a cohort of 294 adult KT recipients (December 2008–February 2020) with CT measurements (muscle quantity: skeletal muscle index; muscle quality: skeletal muscle radiation attenuation). We used mixed linear regression models to estimate 3-year post-KT muscle quantity/quality trajectories. Cox proportional hazard models quantified the association between time-varying pre-/post-KT muscle mass measurements and post-KT mortality and DCGL.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Muscle quantity (−2.4 cm<sup>2</sup>/m<sup>2</sup>/year) and quality (−1.3 HU/year) decreased during the first 2 years post-KT and then remained constant in the third year post-KT. Change in muscle quantity (<i>p</i><sub>interaction</sub> < 0.01) and quality (<i>p</i><sub>interaction</sub> = 0.01) differed by frailty in the first 2 years post-KT; change in muscle quality (<i>p</i><sub>interaction</sub> < 0.01) differed by lower extremity impairment in the third year post-KT. Among frail recipients, lower muscle quantity (per 10 cm<sup>2</sup>/m<sup>2</sup>) was associated with elevated mortality risk (aHR: 2.00, 95% CI: 1.08–3.70), but not among nonfrail recipients. Among older (≥65 years) recipients, lower muscle quantity was associated with increased DCGL risk (aHR: 2.70, 95% CI: 1.04–7.04), but not among younger recipients. Lower muscle quality (per 10 HU) was associated with elevated mortality (aHR: 2.23, 95% CI: 1.61–3.08) and DCGL (aHR: 1.90, 95% CI: 1.16–3.12) risk.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Lower pre-/post-KT muscle quantity/quality were associated with higher risks of post-KT adverse outcomes. Pre-/post-KT rehabilitation to improve muscle quantity/quality may be an effective clinical intervention to minimize risks of adverse post-KT outcomes.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 8","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70281","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Early post-kidney transplant (KT) changes likely impact body composition, resulting in adverse post-KT outcomes. We estimated post-KT trajectories of computed tomography (CT)-based muscle quantity/quality and tested whether they were associated with mortality and death-censored graft loss (DCGL) among frail and nonfrail recipients.
Methods
We leveraged a cohort of 294 adult KT recipients (December 2008–February 2020) with CT measurements (muscle quantity: skeletal muscle index; muscle quality: skeletal muscle radiation attenuation). We used mixed linear regression models to estimate 3-year post-KT muscle quantity/quality trajectories. Cox proportional hazard models quantified the association between time-varying pre-/post-KT muscle mass measurements and post-KT mortality and DCGL.
Results
Muscle quantity (−2.4 cm2/m2/year) and quality (−1.3 HU/year) decreased during the first 2 years post-KT and then remained constant in the third year post-KT. Change in muscle quantity (pinteraction < 0.01) and quality (pinteraction = 0.01) differed by frailty in the first 2 years post-KT; change in muscle quality (pinteraction < 0.01) differed by lower extremity impairment in the third year post-KT. Among frail recipients, lower muscle quantity (per 10 cm2/m2) was associated with elevated mortality risk (aHR: 2.00, 95% CI: 1.08–3.70), but not among nonfrail recipients. Among older (≥65 years) recipients, lower muscle quantity was associated with increased DCGL risk (aHR: 2.70, 95% CI: 1.04–7.04), but not among younger recipients. Lower muscle quality (per 10 HU) was associated with elevated mortality (aHR: 2.23, 95% CI: 1.61–3.08) and DCGL (aHR: 1.90, 95% CI: 1.16–3.12) risk.
Conclusion
Lower pre-/post-KT muscle quantity/quality were associated with higher risks of post-KT adverse outcomes. Pre-/post-KT rehabilitation to improve muscle quantity/quality may be an effective clinical intervention to minimize risks of adverse post-KT outcomes.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.